Current stock page

Stock Analysis

Septerna Inc (SEPN) Stock Analysis

Septerna Inc (SEPN) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

SEPN Stock Analysis Summary

Septerna Inc (SEPN) currently has an AIQ Score of 69/100, indicating a bullish setup. Momentum is the strongest factor at 87/100. Risk is the weakest current factor at 52/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

SEPN at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$42.60
AIQ Score69/100
Overall ViewBullish
Technical Analysis ConsensusNeutral
Market Cap$2B
P/E Ratio (TTM)-33.02
Forward P/E—
EPS (Q3 FY2026)-$0.57
Revenue (Q3 FY2026)$18.88M
Dividend Yield (TTM)0.00%
Beta1.01
Volume337.79K
52-week range$18.64-$53.34
RSI 1447.95
50-Day SMA$40.46
200-Day SMA$33.12
Analyst Price Target—
Next EarningsMar 8, 2027
As of Nov 13, 2026 · Market close

SEPNSepterna Inc

Healthcare / Biotechnology

Leader

Strong Relative Position

BullishEdge 8/10
$42.60+$0.74 (+1.77%)

Latest quote

  • Momentum
    87
  • Value
    55
  • Quality
    66
  • Risk resilience
    52
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

SEPN Stock Analysis Summary

Septerna Inc (SEPN) currently has an AIQ Score of 69/100, indicating a bullish setup. Momentum is the strongest factor at 87/100. Risk resilience is the weakest current factor at 52/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Bullish

In a bullish regime, SEPN has AIQ Score of 69/100 with Momentum base of 87/100 and fading Risk resilience at 52/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (87/100) leads while Risk resilience (52/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 1.77% stock move · SEPN classified in Biotechnology.

Current Evidence

BullishSEPN is in a bullish AIQ regime; Momentum is the strongest visible factor at 87/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is SEPN Bullish or Bearish Right Now?

SEPN currently has a bullish overall setup. Momentum is the strongest factor at 87/100, while Risk Resilience is weakest at 52/100. The current evidence suggests a constructive setup.

Bull Case
  • - Quality is supportive at 66/100.
  • - Momentum is constructive at 87/100.
  • - Price is +5.28% above its 50-day SMA.
Bear Case
  • - Technical consensus has more sell votes than buy votes (22 vs 19).

Current Consensus

SEPN's Technical Analysis Consensus is currently Neutral, with 19 buy, 5 neutral, and 22 sell votes. SEPN's 14-day RSI is 47.95, which places the stock in a neutral momentum range. SEPN's beta is 1.01, indicating market sensitivity broadly in line with the market.

Signal Confidence
Moderate agreement

What Changed in SEPN?

The largest recent change in SEPN is Quality moving down by 12.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
-6.0
Momentum
-6.0
Quality
-12.0
Risk
-1.0

What Would Change the SEPN Outlook?

The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

SEPN Decision Framework

Public evidence layers, setup checks, and risk context for Septerna Inc.

Septerna Inc (SEPN) Stock Analysis

Septerna Inc has an AIQ Score of 69/100 in a Bullish regime. Momentum is strongest at 87/100. Beta is 1.01, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextSEPN is in a Bullish AIQ regime with score 69/100.
Signal ConflictThe primary conflict is that momentum leads at 87/100 while risk lags at 52/100.
Factor EvidenceMomentum 87/100 · Value 55/100 · Quality 66/100 · Risk 52/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Momentum is the strongest factor at 87/100.

TimingPass

Momentum is 87/100 and RSI (14) is 48.0.

Regime fitPass

SEPN is in a Bullish regime at 69/100.

Risk controlWait

Risk factor is 52/100 with beta 1.01 and annual volatility 69.35%.

ConflictWait

Current conflict: momentum leads at 87/100 while risk lags at 52/100.

AIQ Score
69/100
Price
$42.60
Beta
1.01
RSI (14)
48

SEPN Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

SEPN Fundamentals

SEPN valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$18.88M
Net income
-$26.59M
Free cash flow
-$13.9M
View full SEPN fundamental analysis

SEPN Technical Analysis

SEPN technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Neutral
RSI 14
47.95
Price vs SMA-50
+5.28%
View full SEPN technical analysis

SEPN Stock Catalysts

Track SEPN earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Mar 8, 2027
Analyst target
—
News items
0
View SEPN earnings and stock catalysts

SEPN Dividend Analysis

SEPN dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View SEPN dividend history and analysis

SEPN Financial Data

SEPN revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$18.88M
EPS
-$0.57
Periods
8
View SEPN financials

SEPN Risk Analysis

SEPN volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.01
Risk score
52/100
1Y volatility
69.35%
View SEPN risk analysis

SEPN Stock News

SEPN stock news, market tone, recent headlines, and catalyst context.

News items
0
Updated
—
Sentiment
—
Read SEPN stock news

SEPN vs Biotechnology Peers

Current peer cohort: SEPN · SLS · SMMT · SNDX · SRRK. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
SEPN
Current stock
69/10055/10087/10052/1001.4369.35%Current
SLS
SELLAS Life Sciences Group, Inc.
57/100—55/10032/1002.04109.89%SEPN vs SLS
SMMT
Summit Therapeutics Inc.
47/100—65/10038/100-0.0175.92%SEPN vs SMMT
SNDX
Syndax Pharmaceuticals, Inc.
43/10064/10014/10037/100-0.7657.16%SEPN vs SNDX
SRRK
Scholar Rock Holding Corporation
39/100—54/10052/1000.8457.45%SEPN vs SRRK
Pairwise Compare links: SLS · SMMT · SNDX · SRRKSEPN vs SLSSEPN vs SMMTSEPN vs SNDXSEPN vs SRRKCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a SEPN stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for SEPN: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-33.02
As of Nov 13, 2026
Revenue growth
-12.16%
Gross margin
99.56%
Current debt / equity
0.05
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$18.88M
Quarter net income
-$26.59M
Quarter free cash flow
-$13.9M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bullish
Momentum
Mixed
RSI 14
47.95
MACD
1.91

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
52/100
Beta
1.01
Annual volatility
69.35%
Max drawdown
-25.98%

SEPN Stock FAQ

What is SEPN stock price today?

Septerna Inc's current stock price is $42.60. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is SEPN bullish or bearish right now?

SEPN's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is SEPN's market cap?

SEPN's market cap is $2B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is SEPN's current P/E ratio?

SEPN's current P/E ratio is -33.02 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is SEPN's RSI?

SEPN's 14-day RSI is 47.95 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is SEPN above its 50-day and 200-day moving averages?

SEPN is 5.28% from its 50-day SMA and 28.60% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is SEPN's next earnings date?

SEPN's next earnings date is currently listed as Mar 8, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does SEPN pay a dividend?

SEPN's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.